X4 Pharmaceuticals (XFOR) Tops Q3 EPS by 14c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q3 EPS of ($0.01), $0.14 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Cerebras CEO says investors misunderstood margin guidance
• Virax Biolabs announces 1-for-25 reverse stock split on Nasdaq
• GTA VI to catalyze a multi-year improvement in earnings power for TTWO, BTIG says